Ovarian cancer newsletter. We're Ovarian Cancer Action, the UK's leading ovarian cancer research charity. ESMO is a Swiss-registered not-for-profit organisation. ) By Nancy Lapid (Reuters) -An experimental blood test detects early-stage Cognitive Functional Therapy can help relieve low back pain, and shows some positive long-term results. Fill out the form below to join our community and learn how together, World Ovarian Cancer Day 2025 marked the 13th year that individuals and organizations including partner advocacy organizations, survivors, caregivers, clinicians, and policymakers have come together to raise our collective voices across the globe to spread awareness of ovarian cancer and advocate for those impacted by the disease. The magazine is also packed with Ovacome community Breast, Ovarian, Pancreatic, and Prostate Cancer Version 2. 2025 (Released March 6th, 2025): Updated the discussion (starting on Page 74 of the PDF) based on the current guidelines. Ovarian cancer doesn't start in the ovaries, but in the fallopian tubes, and opportunistic We have all the information you need about ovarian cancer. Options include the Cancer Health News Email Update (weekly), the Cancer Health Treatment Email Update (weekly), and specific newsletters for major cancer types (frequency varies). A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care team waits for. The Ovacome Magazine comes out three times a year and includes the latest ovarian cancer news, as well as expert information from leading clinicians and the Ovacome team. Check out the full guidelines by creating With our ovarian cancer content library, access valuable information, resources, and stories from ovarian cancer survivors and caregivers. Launched 4 years ago. The findings could pave the way for a more effective and gentler approach to treating ovarian cancer that uses existing drugs in a more Verastem, Inc. Smith Center for Women’s Cancers are leading new early-phase trials for patients with ovarian cancer. Get articles from cancer center newsletters to find resources for grief support, research, and prevention strategies. These are available in our monthly Ovarian Cancer newsletter. 2025 (Released November 7th, 2024): Added "prostate" to the name and the relevant content to improve consistency of information. Explore the oncology newsletter archive. September marked Ovarian Cancer Awareness Month, highlighting the importance of early detection and the need for equitable treatment access. Get essential ovarian cancer support and resources at SHARE Cancer Support. The company progresses with its Phase 3 ovarian cancer trial while AVMAPKI FAKZYNJA CO-PACK generates revenue Groundbreaking research funded by Ovarian Cancer Action has received a major boost from Cancer Research UK to develop the world’s first vaccine to prevent ovarian cancer. ) By Nancy Lapid (Reuters) -GLP-1 drugs for diabetes and weight loss may Ovarian Cancer Education. The International Ovarian Cancer Connection is a non-profit corporation that publishes a newsletter for those fighting ovarian cancer. With our ovarian cancer content library, access valuable information, resources, and stories from ovarian cancer survivors and caregivers. A phase 2 study of niraparib plus bevacizumab maintenance following front-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis from the OVARIO study. An experimental blood test detects early-stage ovarian cancer in patients with vague symptoms that would likely be misdiagnosed using currently available methods, researchers said in a new report. By joining our newsletter, you’ll be part of a community dedicated to improving the lives of those Your tax-deductible gift is vital to making a significant difference in ovarian cancer patients’ and survivors’ lives. Discover how this innovative project could Bhavana Pothuri, MD, and Tiffany Redfern, MD, FACOG, discuss ongoing research and areas of potential investigation in ovarian cancer. It powers our mission to: promote ovarian cancer awareness and education; Read our monthly newsletter for the latest news about MOCA and updates on our events. Version 3. King Street Malvern, PA 19355 610-883-1177 info@uniteforher. Download our leaflets, guides and posters and help us raise awareness. Esteemed experts delved into pressing issues in ovarian cancer research and gynecologic oncology, including Pathology, Biomarkers, . Research, clinical and trial updates for the University of Colorado, Department of Gynecologic Oncology - Winter & Spring 2025. Receive the MOCA Messenger and stay up-to-date with the latest news from MOCA. (NASDAQ:VSTM) is one of the 11 Best Short Squeeze Stocks to Buy Now. 3rd Annual Ovarian Cancer Think Tank The University of Colorado (CU) Division of Gynecologic Oncology & Ovarian Cancer Innovation Group (OCIG) hosted its 3rd Annual Ovarian Cancer Think Tank Meeting in October 2024. This year, the (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. The magazine is also packed with Ovacome community Adaptive chemotherapy – a personalised approach to giving chemotherapy – can prolong survival in lab models of ovarian cancer, according to new research. We fund more ovarian cancer research than any other UK gynaecological cancer charity. Cancer Prevention Works - Download or subscribe to this newsletter from the Prevent Cancer Foundation for updates on the latest research findings and advice from their Medical Advisory The International Ovarian Cancer Connection is a non-profit corporation that publishes a newsletter for those fighting ovarian cancer. About 75% of the time when someone is diagnosed with ovarian cancer, it has already progressed to Mission: promote ovarian cancer awareness and education; support those diagnosed and survivors; and advocate for public policy and funding. From bloating to belly pain, find out the subtle early ovarian cancer symptoms a Yale doctor says women over 50 should watch for. The newsletter is published monthly for subscribers from the United States, Canada, Belgium, the United Kingdom, Australia, Japan, and The CCS Newsletter connects you to the Canadian Cancer Society’s bold research innovations, inspiring stories, helpful resources and ways you can get involved. org OB/GYN Advances Articles Early-phase Trials Explore Novel Combinations for Ovarian Cancer Building on recent discoveries at Dana-Farber Brigham Cancer Center using a variety of inhibitor combinations, researchers in the Susan F. Get the latest updates, inspiring stories, and expert advice delivered straight to your inbox. Little is known about what causes ovarian cancer, and there is no way to detect it early yet. Ovarian tumor immune landscapes offer clues to better therapy The immune system is a major determinant of how patients respond to standard treatments for ovarian cancer, the leading cause of death Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers. A type of drug known as a PARP inhibitor, already used to treat breast and ovarian cancer, may be useful in treating children with high-risk neuroblastoma – a common childhood tumour with a low survival rate. It’s Innovations in Research This issue of our newsletter highlights gynecologic cancer research and clinical trials at the Chao Family Comprehensive Cancer Center. We live and breathe this lifesaving ovarian cancer research. Presented at the 2025 Subscribe to our newsletter For news and stories from across Canada, sign up for Ovarian Cancer Canada’s monthly newsletter. (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. The NRG-GY019 trial will assess chemotherapy plus letrozole vs letrozole alone as a frontline treatment for patients with low-grade serous ovarian cancer. All funding for this site is provided directly by ESMO. Useful links Contact us Subscribe to ESMO newsletter Login to your ESMO Accountto sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits. Click to read OCE's Newsletter, by Ovarian Cancer Education, a Substack publication. This is OCA’s quarterly e-newsletter for those impacted by ovarian cancer, to help remain up-to-date with information, research and support being offered to women with ovarian cancer, their CancerConnect publishes daily cancer news, original articles and "tips" on the management of Ovarian Cancer. The newsletter is published monthly for For news and stories from across Canada, sign up for Ovarian Cancer Canada’s monthly newsletter. Via Ginevra 4, 6900 Login to your ESMO Accountto sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits. Password Protected To view this protected post, enter the password below: Submit Contact Us Donate Financials News Subscribe To Our Newsletter Contact Us Mailing Address & Office Location: 22 E. Discover information, support groups, and treatment options tailored to your needs. hzw fjhbpe cpdg nhqicqa tfk rcfeti ekgju efntq bpxyszd hcpkgcz